Search

Your search keyword '"Rofe C."' showing total 26 results

Search Constraints

Start Over You searched for: Author "Rofe C." Remove constraint Author: "Rofe C."
26 results on '"Rofe C."'

Search Results

1. Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19

2. Impact of COVID-19 on the imaging diagnosis of cardiac disease in Europe

4. PL02.14 Triaging ILST Screening Participants at Program Entry: Comparative Performance of PanCan versus LungRADSv1.1 Protocol

6. 177Lu-PSMA-617 and Idronoxil in Men with End-Stage Metastatic Castration-Resistant Prostate Cancer (LuPIN) Patient Outcomes and Predictors of Treatment Response in a Phase I/II Trial

7. Impact of COVID-19 on the imaging diagnosis of cardiac disease in Europe

8. Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia: The IAEA INCAPS-COVID Study

9. Final results of a phase I/II prospective dose escalation trial evaluating safety and efficacy of combination 177Lu PSMA 617 and NOX66 in men with end-stage metastatic castration-resistant prostate cancer (LuPIN trial).

10. Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia

12. Phase I/II Trial of the Combination of 177Lutetium Prostate specific Membrane Antigen 617 and Idronoxil (NOX66) in Men with End-stage Metastatic Castration-resistant Prostate Cancer (LuPIN).

19. Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19

20. Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia

21. Coronary artery calcification detected on low-dose computed tomography in high-risk participants of an Australian lung cancer screening program: A prospective observational study.

22. 177 Lu-PSMA-617 and Idronoxil in Men with End-Stage Metastatic Castration-Resistant Prostate Cancer (LuPIN): Patient Outcomes and Predictors of Treatment Response in a Phase I/II Trial.

23. Phase I/II Trial of the Combination of 177 Lutetium Prostate specific Membrane Antigen 617 and Idronoxil (NOX66) in Men with End-stage Metastatic Castration-resistant Prostate Cancer (LuPIN).

24. The effect of VEGF-targeted therapy on biomarker expression in sequential tissue from patients with metastatic clear cell renal cancer.

25. Autoimmune pancreatitis: an illustrated guide to diagnosis.

26. Assessment of pituitary response to nasal application of synthetic gonadotropin-releasing hormone in men.

Catalog

Books, media, physical & digital resources